Company news
Kiniksa Pharmaceuticals International, plc news in 2022
Kiniksa Pharmaceuticals International, plc's news releases, calls and decks from 2022, newest first.
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference
November 29, 2022
Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference
November 22, 2022
Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
October 31, 2022
Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022
October 30, 2022
Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab
September 11, 2022
Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference
August 2, 2022
Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 2, 2022
Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab
August 2, 2022
Kiniksa Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022
August 1, 2022
Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 2, 2022
Kiniksa Pharmaceuticals to Report First Quarter 2022 Financial Results on May 3, 2022
May 1, 2022
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
February 21, 2022
Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration
February 21, 2022
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
February 17, 2022
Kiniksa Provides Corporate Update and Outlines Anticipated 2022 Milestones
January 9, 2022
Kiniksa Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference
January 2, 2022
Calls in 2022
Decks in 2022
- Q3 2022 Earnings Presentation
Earnings · 18 slides · Nov 1, 2022